TENX - TENAX THERAPEUTICS, INC.

QQQ $ 634.27 $ 0.00 (0 %)

DIA $ 475.85 $ 0.00 (0 %)

SPY $ 685.12 $ 0.00 (0 %)

TLT $ 90.40 $ 0.00 (0 %)

GLD $ 370.49 $ 0.00 (0 %)

Previous Close

$ 7.47

Open

$ 7.57

Bid

$ 7.28 x 152

Ask

$ 7.70 x 10

Day's Range

-- - --

52 Week Range

$ 4.32 - $ 8.24

Volume

88,140

Average Volume

Market Cap

34.08M

Beta (5Y Monthly)

$ 0.73

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2025	06-30-2025	10-Q
2	05-14-2025	03-31-2025	10-Q
3	03-25-2025	12-31-2024	10-K
4	11-13-2024	09-30-2024	10-Q
5	08-13-2024	06-30-2024	10-Q
6	05-14-2024	03-31-2024	10-Q
7	03-28-2024	12-31-2023	10-K
8	11-13-2023	09-30-2023	10-Q
9	08-14-2023	06-30-2023	10-Q
10	05-15-2023	03-31-2023	10-Q
11	03-31-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-16-2022	03-31-2022	10-Q
15	03-29-2022	12-31-2021	10-K
16	11-15-2021	09-30-2021	10-Q
17	08-16-2021	06-30-2021	10-Q
18	05-17-2021	03-31-2021	10-Q
19	03-31-2021	12-31-2020	10-K
20	11-16-2020	09-30-2020	10-Q
21	08-14-2020	06-30-2020	10-Q
22	05-15-2020	03-31-2020	10-Q
23	03-30-2020	12-31-2019	10-K
24	11-14-2019	09-30-2019	10-Q
25	08-14-2019	06-30-2019	10-Q
26	05-15-2019	03-31-2019	10-Q
27	04-01-2019	12-31-2018	10-K
28	11-14-2018	09-30-2018	10-Q
29	08-14-2018	06-30-2018	10-Q
30	05-15-2018	03-31-2018	10-Q
31	04-02-2018	12-31-2017	10-K
32	11-09-2017	09-30-2017	10-Q
33	08-09-2017	06-30-2017	10-Q
34	05-10-2017	03-31-2017	10-Q
35	03-16-2017	12-31-2016	10-K
36	11-09-2016	09-30-2016	10-Q
37	08-09-2016	06-30-2016	10-Q
38	05-10-2016	03-31-2016	10-Q
39	12-10-2015	10-31-2015	10-Q
40	09-09-2015	07-31-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Tenax Therapeutics Secures European Patent...
09/16/2025 11:11:32

Tenax Therapeutics Expands Global Rights t...
09/09/2025 12:10:56

On September 3, 2025, Tenax Therapeutics, Inc. (the "Company") and Orion Corporation ("Orion") entered into an ...

Piper Sandler Initiates Coverage On Tenax ...
09/08/2025 10:39:49

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Tenax Therapeutics (NASDAQ:TENX) with a Overweight rating and ann...

Guggenheim Maintains Buy on Tenax Therapeu...
08/14/2025 13:36:10

Guggenheim analyst Seamus Fernandez maintains Tenax Therapeutics (NASDAQ:TENX) with a Buy and lowers the price target from $...

Tenax Therapeutics Q2 EPS $(0.27) Misses $...
08/13/2025 20:17:14

Tenax Therapeutics Q1 EPS $(0.28) Misses $...
05/14/2025 20:12:57

Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of ...

Tenax Therapeutics Q4 2024 GAAP EPS $(0.18...
03/25/2025 20:09:38

Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(...

Tenax Therapeutics Announces $25M Private ...
03/05/2025 13:49:44

Tenax Therapeutics, Inc. (NASDAQ:TENX) (the "Company" or "Tenax Therapeutics"), a Phase 3, development-stage ph...

Tenax Therapeutics AnnounceS FDA Review Co...
03/05/2025 13:47:27

Tenax Therapeutics, Inc. (NASDAQ:TENX) ("Tenax Therapeutics" or the "Company"), a Phase 3, development-stage ph...

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
01/16/2025 21:05:59

Tenax Therapeutics Appoints Thomas A. McGa...
12/04/2024 22:20:08

- SEC Filing

Tenax Therapeutics Q3 2024 GAAP EPS $(0.19...
11/13/2024 12:08:57

Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(...

this-sempra-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday

This Sempra Analyst Begins Coverage On A B...
10/24/2024 11:40:24

Leerink Partners Initiates Coverage On Ten...
10/24/2024 11:20:10

Leerink Partners analyst David Risinger initiates coverage on Tenax Therapeutics (NASDAQ:TENX) with a Outperform rating and ...

Guggenheim Initiates Coverage On Tenax The...
10/14/2024 11:17:29

Guggenheim analyst Seamus Fernandez initiates coverage on Tenax Therapeutics (NASDAQ:TENX) with a Buy rating and announces P...

William Blair Initiates Coverage On Tenax ...
09/30/2024 14:12:36

William Blair analyst Matt Phipps initiates coverage on Tenax Therapeutics (NASDAQ:TENX) with a Outperform rating.

Tenax Therapeutics Q2 2024 Adj EPS $(1.83)...
08/13/2024 20:13:13

Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(1.83) per share which beat the analyst consensus estimate of $(...

Market-Moving News for August 6th
08/06/2024 12:23:44

LUMN: 58% | Lumen Technologies shares are trading higher after the company announced it secured $5 billion in new business from...

Tenax Therapeutics Secures $100M In Oversu...
08/06/2024 11:16:26

The private placement was led by new investor BVF Partners LP, with participation from other new investors, including Venrock H...

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
07/04/2024 16:31:04